Form 4: Chemours Co: Executive Alvenia Scarborough Reports Acquisition of Shares and Stock Options

Alvenia Scarborough, SVP Corp Communications & CBO of Chemours Co, reports acquiring shares and stock options on March 3, 2025.

Summary

• On March 3, 2025, Alvenia Scarborough, SVP Corp Communications & CBO of Chemours Co, reported transactions involving the company's securities.
• Scarborough acquired 6,042 shares of common stock at $0.00, resulting in a total of 21,812.1662 shares beneficially owned.
• Additionally, Scarborough acquired stock options to buy 20,083 shares at an exercise price of $13.86 and 20,886 shares at an exercise price of $15.25, both sets of options expiring on March 3, 2035.
• These options vest in three equal annual installments beginning on March 3, 2026.
• The $15.25 strike price represents a 10 percent premium above the closing price of the Company common stock on the date of grant.
• The RSU award is scheduled to vest in three equal annual installments beginning on March 1, 2026.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. The acquisition of shares and options by an executive suggests confidence, but it's a routine filing and doesn't provide strong directional information.

Positives

• The acquisition of shares and stock options by a company executive can be seen as a positive sign, indicating confidence in the company's future performance.
• The vesting schedule of the options and RSUs incentivizes the executive to remain with the company and contribute to its long-term success.

Future Outlook

The vesting schedules for the RSUs and stock options suggest a long-term commitment from the executive to the company's success.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. These filings are closely watched by investors for insights into management's perspective on the company's stock.

Comparison to Industry Standards

• Executive compensation packages often include a mix of salary, stock options, and restricted stock units (RSUs).
• The vesting schedules and exercise prices of these instruments are typically designed to align the executive's interests with those of shareholders.
• The specific terms of these packages can vary widely depending on the company's size, industry, and performance.
• Comparing Chemours' executive compensation practices to those of its peers (e.g., Dow, DuPont) would provide a more comprehensive assessment.

Stakeholder Impact

• The reported transactions provide shareholders with insight into the executive's holdings and incentives.
• The vesting schedules for the options and RSUs could potentially impact employee morale, as they align executive compensation with company performance.

Key Dates